| |
|
|
 Février 2017 - La biologie industrielle : enjeux technologiques, économiques et sociétaux
Role of Nutritional Therapy in Healthcare Innovation: The Need for Reshaping Regulatory Paradigms
By Manfred RUTHSATZ,
PhD Nestlé Health Science, Global Head of Regulatory Advocacy
Over the next decades, the world will undergo profound changes, with its population approaching ten billion, senior citizens making up one out of five, non-communicable diseases (NCDs) increasingly outnumbering infectious diseases [1], and healthcare costs threatening to reach an ever higher percentage of countries’ GDPs. As daunting as these figures might appear, new scientific insights and technological opportunities coming at an unprecedented pace promise new perspectives and potential solutions to currently unmet needs. ‘Omics’ diagnostics will revolutionize the way we approach prevention, personalize nutrition in healthcare, and how a patient is to be defined. Novel nutrition therapeutic findings will transform disease management, and the microbiome will become a new force in targeting holistic healthcare solutions. This article presents pertinent focus areas to encourage dialogue with regulators, policy makers, healthcare professionals and other stakeholders to revisit current regulatory and policy frameworks at the food-medicine continuum and their respective interpretation, with regards to healthcare.
 Télécharger gratuitement l'article
Retour au sommaire
 February 2017 - Industrial biology: the technological, economic and societal issues of biotechnology
Role of Nutritional Therapy in Healthcare Innovation: The Need for Reshaping Regulatory Paradigms
Manfred Ruthsatz,
PhD, Nestlé Health Science, Global Head of Regulatory Advocacy
Over the next decades, the world will undergo profound changes, with its population approaching ten billion, senior citizens making up one out of five, non-communicable diseases (NCDs) increasingly outnumbering infectious diseases, and healthcare costs threatening to reach an ever higher percentage of countries’ GDPs. As daunting as these figures might appear, new scientific insights and technological opportunities coming at an unprecedented pace promise new perspectives and potential solutions to currently unmet needs. ‘Omics’ diagnostics will revolutionize the way we approach prevention, personalize nutrition in healthcare, and how a patient is to be defined. Novel nutrition therapeutic findings will transform disease management, and the microbiome will become a new force in targeting holistic healthcare solutions.
This article presents pertinent focus areas to encourage dialogue with regulators, policy makers, healthcare professionals and other stakeholders to revisit current regulatory and policy frameworks at the food-medicine continuum and their respective interpretation, with regards to healthcare.
Retour au sommaire
 Febrero 2017 - La biología industrial, desafíos tecnológicos, económicos y sociales
Role of Nutritional Therapy in Healthcare Innovation: The Need for Reshaping Regulatory Paradigms (El rol de la Terapia Nutricional en la Innovación Sanitaria. La necesidad de reformar los paradigmas regulatorios)
Manfred Ruthsatz,
Nestlé Health Science, Jefe mundial de asuntos reglamentarios
Over the next decades, the world will undergo profound changes, with its population approaching ten billion, senior citizens making up one out of five, non-communicable diseases (NCDs) increasingly outnumbering infectious diseases, and healthcare costs threatening to reach an ever higher percentage of countries’ GDPs. As daunting as these figures might appear, new scientific insights and technological opportunities coming at an unprecedented pace promise new perspectives and potential solutions to currently unmet needs. ‘Omics’ diagnostics will revolutionize the way we approach prevention, personalize nutrition in healthcare, and how a patient is to be defined. Novel nutrition therapeutic findings will transform disease management, and the microbiome will become a new force in targeting holistic healthcare solutions.
This article presents pertinent focus areas to encourage dialogue with regulators, policy makers, healthcare professionals and other stakeholders to revisit current regulatory and policy frameworks at the food-medicine continuum and their respective interpretation, with regards to healthcare.
Retour au sommaire
|
|
